PACS Group (NYSE:PACS - Get Free Report) will likely be announcing its Q3 2026 results after the market closes on Wednesday, November 25th. Analysts expect PACS Group to post earnings of $0.5790 per share and revenue of $1.46 billion for the quarter. Parties may review the information on the company's upcoming Q3 2026 earnings report for the latest details on the call scheduled for Wednesday, November 4, 2026 at 11:30 AM ET.
PACS Group (NYSE:PACS - Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.58 by $0.05. PACS Group had a net margin of 4.87% and a return on equity of 31.98%. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.46 billion. On average, analysts expect PACS Group to post $2.05 EPS for the current fiscal year and $2.66 EPS for the next fiscal year.
PACS Group Stock Performance
NYSE PACS opened at $48.44 on Wednesday. The company's 50 day moving average is $45.48 and its 200-day moving average is $40.52. PACS Group has a 12-month low of $14.09 and a 12-month high of $51.68. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.22. The firm has a market cap of $7.69 billion, a P/E ratio of 22.37, a price-to-earnings-growth ratio of 1.59 and a beta of -0.14.
Insiders Place Their Bets
In other PACS Group news, CEO Jason Murray sold 167,434 shares of the firm's stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $50.24, for a total value of $8,411,884.16. Following the sale, the chief executive officer owned 53,954,101 shares of the company's stock, valued at $2,710,654,034.24. This trade represents a 0.31% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Joshua Jergensen sold 40,000 shares of PACS Group stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $43.13, for a total value of $1,725,200.00. Following the sale, the chief operating officer owned 2,496,320 shares of the company's stock, valued at approximately $107,666,281.60. This trade represents a 1.58% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,545,550 shares of company stock worth $71,404,223 in the last ninety days. 70.10% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
Several research analysts recently commented on the stock. UBS Group raised their price objective on shares of PACS Group from $60.00 to $67.00 and gave the stock a "buy" rating in a report on Thursday, November 5th. Stephens boosted their target price on shares of PACS Group from $60.00 to $64.00 and gave the company an "overweight" rating in a report on Thursday, November 5th. Truist Financial restated a "buy" rating and set a $65.00 target price (up from $62.00) on shares of PACS Group in a research report on Thursday, November 5th. Zacks Research lowered PACS Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 9th. Finally, Oppenheimer lifted their price target on PACS Group from $48.00 to $57.00 and gave the company an "outperform" rating in a research report on Monday, August 10th. Seven analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $62.50.
Check Out Our Latest Stock Report on PACS Group
PACS Group Company Profile
(
Get Free Report)
PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider PACS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.
While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.